ZRO — Biosenta Balance Sheet
0.000.00%
Last trade - 00:00
- CA$14.82m
- CA$20.42m
- CA$0.00m
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.01 | 0.044 | 0.112 | 0.027 | 0.006 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.01 | 0.031 | 0.003 | 0.139 | 0.02 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.02 | 0.109 | 0.264 | 0.256 | 0.092 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0 | — | 0 | — | 0.016 |
Net Intangible Assets | |||||
Total Assets | 0.02 | 0.109 | 0.264 | 0.256 | 0.108 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.41 | 1.94 | 2.8 | 3.12 | 2.67 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.45 | 1.98 | 2.86 | 3.18 | 7.96 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.43 | -1.87 | -2.59 | -2.92 | -7.86 |
Total Liabilities & Shareholders' Equity | 0.02 | 0.109 | 0.264 | 0.256 | 0.108 |
Total Common Shares Outstanding |